All lobbying filings

McDermott+

McDermott+ filed a Q3 termination report for American Academy of Ophthalmology on August 28, 2026, reporting $20,000 in lobbying income.

Lobbying for American Academy of Ophthalmology · Health Care Association

As filed: MCDERMOTT+ for AMERICAN ACADEMY OF OPHTHALMOLOGY.

All filings by McDermott+ · Everything American Academy of Ophthalmology has reported

Filing · LD-2 quarterly report Q3 termination

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Aug 28, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Representation ended

Aug 31, 2026

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 4

DEBRA CURTIS

Previously held: 1998-2013: Legislative Director, Chief of Staff, Rep. Pete Stark; jointly Professional Staff on Committee on Ways and Means, Health Subcommittee
RODNEY WHITLOCK

Previously held: 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood
JOSH JORGENSEN

Previously held: 2017-2020: Senior Legislative Correspondent; Legislative Aide, Sen. Mike Rounds
MADALYN NEWS

Previously held: 2020: Paid Intern, Rep. Madeleine Dean

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Issues relating to Medicare including step therapy for Part B drugs and global surgical payments.

Health Issues

Issues relating to Medicare including step therapy for Part B drugs, global surgical payments, and drug shortages.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.